Terlipressin 1mg/10mL Injection

Terlipressin 1mg/10mL Injection is a vasopressin analogue used in specialist hospital care for selected hepatorenal-syndrome cases and bleeding oesophageal varices. It treats these specific complications of advanced liver disease rather than the underlying cirrhosis.
Administer intravenously under a hospital protocol with oxygenation, circulation, fluid balance and renal response monitored. Reconstitution and dosing must account for whether strength is expressed as terlipressin or its acetate salt.
Predominantly V1-receptor-mediated vasoconstriction reduces splanchnic blood flow and can improve effective renal perfusion in hepatorenal syndrome.
Abdominal pain, nausea, diarrhoea and circulatory effects may occur; respiratory failure and ischaemia are major serious risks.
Do not initiate in hypoxia or worsening respiratory symptoms. Review fluid overload and cardiac, peripheral or mesenteric ischaemia; oxygen saturation requires close surveillance.
Can improve renal function in selected hepatorenal-syndrome patients or reduce portal inflow during variceal bleeding.
No. It requires monitored hospital administration.
Treatment can cause serious or fatal respiratory failure.
No. It addresses specific complications rather than curing cirrhosis.
Excess fluid can increase respiratory risk during treatment.
No. Salt and active-base expressions must be interpreted from the product label.
These can indicate ischaemia and need immediate clinical assessment.
No. Establishing hepatorenal syndrome and excluding other causes is essential.
No. Albumin and terlipressin have different roles within the specialist protocol.
Hepatorenal syndrome: kidney dysfunction associated with advanced liver disease. Splanchnic: relating to abdominal-organ circulation. Ischaemia: insufficient blood supply.; AR: Terlipressin 1mg/10mL حقن; FR: Terlipressin 1mg/10mL injection; PT: Terlipressin 1mg/10mL injeção; ES: Terlipressin 1mg/10mL inyección; RU: Terlipressin 1mg/10mL инъекция; ID: Terlipressin 1mg/10mL injeksi; VI: Terlipressin 1mg/10mL thuốc tiêm; MS: Terlipressin 1mg/10mL suntikan; TL: Terlipressin 1mg/10mL iniksyon; ZH-SG: Terlipressin 1mg/10mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Terlipressin 1mg/10mL Injection under Critical Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Terlipressin 1mg/10mL Injection